These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 11134797
1. Combined analysis of autoantibodies against beta-cells for prediction of pancreas allograft failure. Da Silva M, Thivolet C, Lefrançois N, Bosshard S, Sepeteanu I, Petruzzo P, Dubernard JM, Martin X. Transplant Proc; 2000 Dec; 32(8):2773. PubMed ID: 11134797 [No Abstract] [Full Text] [Related]
2. Islet autoantibodies and their use in predicting insulin-dependent diabetes. Bonifacio E, Bingley PJ. Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639 [No Abstract] [Full Text] [Related]
3. Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation. Lohmann T, Klemm T, Geissler F, Uhlmann D, Ludwig S, Hauss J, Witzigmann H. Transplant Proc; 2002 Sep; 34(6):2249-50. PubMed ID: 12270385 [No Abstract] [Full Text] [Related]
4. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG. Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046 [Abstract] [Full Text] [Related]
11. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy. Zerbini G, Bazzigaluppi E, Mangili R, Bosi E, Bonifacio E. Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029 [No Abstract] [Full Text] [Related]
12. Selecting culprits in type 1 diabetes beta-cell killing. Lernmark A. J Clin Invest; 1999 Dec; 104(11):1487-9. PubMed ID: 10587509 [No Abstract] [Full Text] [Related]
13. Towards a World Health Organization (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies. Lernmark A, Kolb H, Mire-Sluis T. Diabetologia; 1999 Mar; 42(3):381-2. PubMed ID: 10096794 [No Abstract] [Full Text] [Related]
14. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function. Fukui M, Nakamura N, Nakano K, Kondo M. Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760 [No Abstract] [Full Text] [Related]
19. [Autoantibodies in type 1 diabetes mellitus]. Ziegler M, Ziegler B. Z Arztl Fortbild (Jena); 1994 Aug 15; 88(7-8):561-5. PubMed ID: 7856261 [No Abstract] [Full Text] [Related]
20. Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies. Mujtaba MA, Fridell J, Book B, Faiz S, Sharfuddin A, Wiebke E, Rigby M, Taber T. Clin Transplant; 2015 Nov 15; 29(11):991-6. PubMed ID: 26289931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]